VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 11 filers reported holding VISTAGEN THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $112,000 | -40.1% | 162,714 | -6.9% | 0.00% | 0.0% |
| Q3 2019 | $187,000 | +48.4% | 174,714 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $126,000 | -43.8% | 174,714 | -0.1% | 0.00% | -50.0% |
| Q1 2019 | $224,000 | +9.8% | 174,914 | +28.5% | 0.00% | 0.0% |
| Q4 2018 | $204,000 | +13.3% | 136,114 | +9.2% | 0.00% | 0.0% |
| Q3 2018 | $180,000 | +85.6% | 124,614 | +19.3% | 0.00% | +100.0% |
| Q2 2018 | $97,000 | 0.0% | 104,414 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $97,000 | -16.4% | 104,414 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $116,000 | +61.1% | 104,414 | +131.6% | 0.00% | 0.0% |
| Q3 2017 | $72,000 | -14.3% | 45,076 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $84,000 | -4.5% | 45,076 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $88,000 | +144.4% | 45,076 | +371.7% | 0.00% | 0.0% |
| Q4 2016 | $36,000 | -10.0% | 9,556 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $40,000 | +37.9% | 9,556 | +28.4% | 0.00% | – |
| Q2 2016 | $29,000 | – | 7,441 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 11,736,283 | $22,886,000 | 9.62% |
| VR Adviser, LLC | 16,047,286 | $31,292,000 | 4.28% |
| COMMODORE CAPITAL LP | 8,464,999 | $16,507,000 | 3.82% |
| Ghost Tree Capital, LLC | 2,000,000 | $3,900,000 | 1.40% |
| EPIQ PARTNERS, LLC | 1,002,350 | $1,955,000 | 1.04% |
| HighVista Strategies LLC | 577,031 | $1,125,000 | 0.90% |
| SPHERA FUNDS MANAGEMENT LTD. | 4,024,938 | $7,849,000 | 0.86% |
| NEA Management Company, LLC | 16,302,596 | $31,790,000 | 0.64% |
| Nicholas Investment Partners, LP | 4,288,077 | $8,362,000 | 0.53% |
| Logos Global Management LP | 2,000,000 | $3,900,000 | 0.40% |